Alain L. Fymat, BA, BS, MA, MS, PhD, PhD, Founding Chairman, President & CEO, Professor
(For a more detailed CV, please search Alain L. Fymat in your preferred search engine. Profiles can also be found in Cambridge Who's Who; LinkedIn; BiomedExperts; TED.com; Zoominfo & Xing; Spoke.com)
Alain L. Fymat received a BA in Mathematics & Physics from the University of Bordeaux, Bordeaux, France, a BS in Engineering from the Ecole Nationale Superieure d'Ingenieurs in Paris, France, an MA in Applied Physics from the Universite de Paris-Sorbonne, Paris, France, and an MS in Mathematics & Physics from the Universite de Bordeaux, France. Under the sponsorship of the U.S. Agency for International Development (USAID), he received a PhD#1 in Physics-Atmospheric Sciences from the University of California at Los Angeles (UCLA). He then concurrently joined the UCLA Faculty as Assistant Professor & Graduate Lecturer of Atmospheric Sciences, and the California Institute of Technology, Jet Propulsion Laboratory (CIT/JPL) as Senior Scientist and Technical Staff Member.
For the next 15 years, Dr. Fymat was actively involved in the U.S. unmanned space program headquartered at CIT/JPL in Pasadena, California, a prime contractor of the U.S. National Aeronautics & Space Administration (NASA). During that time period, he was a Co-Investigator on three space and Earth satellite experiments. He was also Principal Investigator of five basic & applied science research programs. He founded and directed the Atmospheric Scattering Research Laboratory from funds secured both from NASA and CIT/JPL. In the course of these activities, he was appointed a Member of the Advisory Group for Post-Doctoral Programs of the U.S. National Academy of Sciences, National Research Council (NAS/NRC). He was associated with the Advisory Group for Research & Development of the North Atlantic Treaty Organization (NATO/AGARD). He was also a U.S. Delegate to several international organizations (International Commission on Radiation; International Union of Geodesy and Geophysics; International Association of Meteorology & Atmospheric Physics; International Committee on Space Research; World Meteorological Organization) .
During his tenure at CIT/JPL, Dr. Fymat was also jointly a Visiting Professor of Geodesy & Geophysics at the University of Southern California in Los Angeles. Subsequently, he was invited by the Government of France and the University of Lille to spend a one-year sabbatical as Invited Professor of Physics and Director of Research with charge to develop a joint France-USA space science program that is continuing to this date. During that stay, he developed an active joint research program between CIT/JPL and the University of Lille, and was also selected to be the thesis advisor of two doctoral students who successfully completed their Sc.D. degree.
From 1982 to 1989, Dr. Fymat joined the scientific and management ranks of Gencorp Aerojet ElectroSystems Company, a major U.S. defense contractor. He became Co-Investigator in six classified programs in the U.S. Space Defense Initiative (SDI) and a Principal Investigator of two classified programs in the U.S. Ballistic Missile Defense (BMD) Program.
After a long foray in the space and defense programs, and in a period of waning public interest in space activities, Dr. Fymat rejoined the student body of UCLA Medical School to receive a PhD#2 in Medical & Radiological Physics. Following a two-year fellowship training under the sponsorship of the National Cancer Institute, and Clinics in three sub-specialties (Diagnostic Radiology, Radiation Oncology, and Nuclear Medicine), he was appointed Associate Professor of Radiological Sciences at the UCLA Center for the Health Sciences, School of Medicine. Concurrently, he held a joint appointment at the UCLA/Olive View Medical Center as Medical Physicist and Graduate Lecturer of Radiological Sciences.
Dr. Fymat continued his medical career by joining the UCLA/Drew Medical Center and the Charles R. Drew Post-Graduate Medical School in Los Angeles as Professor of Radiology and Director of the campus-wide Division of Biomedical & Biobehavioral Research in the Office of the Vice President for Academic Affairs and Dean of the College of Medicine. Under his stewardship, the research program grew by nearly one order of magnitude in a two-year time span.
Public service to assuage the plight of American Veterans of past wars caused Dr. Fymat to join the U.S. Veterans Administration (VA) Healthcare System, the largest of its kind in the world and the biggest educator of physicians in the U.S. At the VA Medical Center in Loma Linda, California, he was appointed Scientific Director of Radiology and Director of the Magnetic Resonance Imaging Center and, for a brief period, Acting Chair of the Radiology Dpartment. There, he contributed to the clinical training of resident physicians in radiological sub-specialties. He concurrently held a joint appointment at the Loma Linda University Medical Center , School of Medicine, as Professor in the Departments of Radiology and Radiation Medicine (Radiation Oncology) to lecture to post-graduate medical students, physicians and Residents in preparation for their Board of Radiology examinations. In the late 1990's, medical research within the VA system was under scrutiny, and the VA Under Secretary for Health created the new agency-wide Office of Research Oversight (ORO). Dr. Fymat became the Deputy Director for the ORO Western Region overseeing an area nearly 35% of the U.S. and its territories.
In 2006, after a one-year stint at "retirement" and volunteer research activity in critical care medicine, Dr. Fymat was invited to join the Weil International Institute of Critical Care Medicine, Rancho Mirage, California, a
non-profit 501(c)(3) institution dedicated to saving lives through intensive care research and education since 1959. He served as its Executive Vice President & Chief Operating Officer and Professor. With senior management, he also helped to create the for-profit entity "Resuscitation International, Inc." (RII) to receive and commercialize Institute's technologies, and served on its Board of Directors.
As an Executive-in- Residence at the University of California in Riverside, Palm Desert Graduate Center, he lectured to graduate MBA students at the Richard J. Heckmann International Center for Entrepreneurial Management. He is also a Founding Member of the Business Leaders Round Table to promote the economic development of the greater Coachella Valley area, particularly in the health, pharmaceutical, and medical device industries.
All along his career, Dr. Fymat has been a member or chair of numerous international, national, California State, and Los Angeles County governments' committees, and held several international and national offices. As a U.S. Delegate, he participated to the deliberations of several international scientific organizations. He received numerous distinctions and awards and has published extensively (in excess of 300 publications including patents, books & monographs, book chapters, refereed articles, technical reports, abstracts of presentations at professional meetings & symposia, and NASA Briefs for Technical Inventions). He received numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is a current Editor of the "Journal of Nanobiotechnology" (an international open journal of PubMed) and a Reviewer for "Interventional Medicine and Applied Sciences", a Journal of the Hungarian Academy of Sciences and the Emmelweiss University. He is also a Visiting Consultant to the "Advanced Center for Cardiovascular Disease and Research, Rockland Hospital", New Delhi, India. He is further the Chairman of the Medical & Technical Advisory Board of Janus Medical Systems Pte, Ltd (Singapore) that develops breakthrough electronic personal and hospital medical records. He is a member of the Executive Council, Director of the Scientific Directorate, and Chairman of the Scientific Committee of the Society for the Advancement of Science in Africa (SASA). He chaired the Scientific Committee of the Joint Inaugural Meeting and First International Conference of SASA, which was held at the University of Limpopo, South Africa, April 25-28, 2013.
The International Institute of Medicine and Science is Dr. Fymat's latest entreprise and his long-time dream. Drawing on his varied background and expertise in science and medicine, he hopes to further bridge these two fields for the preservation and betterment of life through advanced medical science research, education and service.
Eytan Ellenberg, MD, PhD, MBA, Vice President for Business Development.
Eytan Ellenberg received his MD degree in Public Health and Social Medicine in October 2004 from the University of Paris-Sorbonne ("Nouvelle Sorbonne Paris III"). He also holds a PhD in Medical Linguistics from the same institution, an MBA from the Sorbonne Business School, and an Ultimate CRA Development in Pharmaceutics in 2010. Prior to that, he received a specialized Master degree in Hospital Risk Management from the Ecole Centrale de Paris in 2003 and a Master degree in Biostatistics and Modeling from the University of Paris, Faculty of Medicine Paris VII in 2003.
After several Internships in Public Health (at the French Ministry of Labor and Social Affairs with emphasis in Suicide Prevention and Psychiatry in Prisons, 2000-2001; at the European Hospital Georges Pompidou with emphasis on Hospital Risk Management and Information Systems, 2001; at the Pediatric Hospital Robert Debre with emphasis on Accreditation and Hospital Risk Management, 2001-2002; at the Ethical Committee of Hopitals of Paris with emphasis on research coordination on application of French Law and Ethics and Bioethics in hospitals and Ethics in Europe, 2002-2004), Dr. Ellenberg became research coordinator and lecturer in the Faculty of Medicine, Paris-Sud, Department of Research on Ethics, 2004. He was also Medical Advisor for Arsenal/TBWA WorldHealth, 2004-2006. His charge was in Ethics (neurology, pain, ophthalmology, diabetes, cardiovascular, oncology, dermatology,etc.), pre-launches and launches (for Pfizer, Grunenthal, Abott, Schering-Plough, Novartis, and others), and Public Health (healthcare networks, French national insurance). He developed expertise in copyrighting, communication strategy and operational planning, strategic planning, global communication counseling, Key Opinion Leaders' relations and medical education, board organization, public relations, and international communication.
Dr. Ellenberg subsequently became Medical Director of Orkyn (Home Care provider, and a subsidiary of Air Liquide), 2007-2010. He was responsible for quality of care (protocols, procedures, clinical follow-up of 85,000 patients for sleep apnea, respiratory failure, diabetes, Parkinson, Alzheimer) and supervised 700 home care technicians, nurses and dietitians. He was also responsible for Key Opinion Leaders' relations (in pneumonology, diabetology, neurology), patient education and disease management programs, especially in COPD), and clinical studies (interaction with sales forces, business development, marketing and innovation).
After a sabbatical as a Visiting Professor at the Universidade Federal Do Estado Do Rio de Janeiro-UNIRIO, Brazil, in Medical Linguistics, 2010, he assumed his current position since July 2010 as Medical Director of Air Liquide Sante International ALSI (Division of Home Care Development). He is charged to define and improve the home care positioning of ALSI, develop new indications for oxygen use in neurology and cardiology, define disease management programs, and increase market access.
Dr. Ellenberg has published extensively on clinical and hospital risk management, and on bioethics and public health. He is the author of a book on the dangers posed by hospitalization.